These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7667898)

  • 81. Potent antihypertrophic effect of the bradykinin B2 receptor system on the renal vasculature.
    Tsuchida S; Miyazaki Y; Matsusaka T; Hunley TE; Inagami T; Fogo A; Ichikawa I
    Kidney Int; 1999 Aug; 56(2):509-16. PubMed ID: 10432390
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Renal kallikrein-kinin system.
    Scicli AG; Carretero OA
    Kidney Int; 1986 Jan; 29(1):120-30. PubMed ID: 3007849
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [The effect of physical training on the indices of the general hemodynamics and kinin-kallikrein system activity in hypertension patients].
    Fomenko GV; Kuznetsov VA; Nikolaeva LF; Bol'shakova TD; Arabidze GG; Titov VN
    Ter Arkh; 1991; 63(4):34-7. PubMed ID: 2068675
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Kallikreins, kininogens and kinin receptors on circulating and synovial fluid neutrophils: role in kinin generation in rheumatoid arthritis.
    Cassim B; Shaw OM; Mazur M; Misso NL; Naran A; Langlands DR; Thompson PJ; Bhoola KD
    Rheumatology (Oxford); 2009 May; 48(5):490-6. PubMed ID: 19254919
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Roles for the kallikrein-kinin system in inflammatory exudation and pain: lessons from studies on kininogen-deficient rats.
    Ueno A; Oh-ishi S
    J Pharmacol Sci; 2003 Sep; 93(1):1-20. PubMed ID: 14501145
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The kallikrein-kinin system along the different stages of gestation: experimental and clinical findings.
    Valdés G; Corthorn J; Figueroa CD
    Biol Res; 1998; 31(3):235-41. PubMed ID: 9830511
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Possible mediators in hypertension: renal factors.
    Bergman SM; Curtis JJ
    Semin Nephrol; 1996 Mar; 16(2):134-9. PubMed ID: 8668861
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The kallikrein-kinin system in health and in diseases of the kidney.
    Kakoki M; Smithies O
    Kidney Int; 2009 May; 75(10):1019-30. PubMed ID: 19190676
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Inhibitor complexes of the plasma kallikrein-kinin system and outcome prediction in patients following admission for chest pain.
    Pönitz V; Govers-Riemslag JW; Brügger-Andersen T; ten Cate H; Nilsen DW
    J Thromb Haemost; 2009 Jul; 7(7):1231-3. PubMed ID: 19422440
    [No Abstract]   [Full Text] [Related]  

  • 90. The kallikrein-kinin system: a promising therapeutic target for traumatic brain injury.
    Hopp S; Albert-Weissenberger C
    Neural Regen Res; 2015 Jun; 10(6):885-6. PubMed ID: 26199598
    [No Abstract]   [Full Text] [Related]  

  • 91. A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept.
    Katori M; Majima M
    Pharmaceuticals (Basel); 2010 Jan; 3(1):59-109. PubMed ID: 27713243
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats.
    Ito H; Hayashi I; Izumi T; Majima M
    Br J Pharmacol; 2003 Jan; 138(1):225-33. PubMed ID: 12522094
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    Lassila M; Finckenberg P; Pere AK; Krogerus L; Ahonen J; Vapaatalo H; Nurminen ML
    Br J Pharmacol; 2000 Jul; 130(6):1339-47. PubMed ID: 10903974
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Early increases in renal kallikrein secretion on administration of potassium or ATP-sensitive potassium channel blockers in rats.
    Fujita T; Hayashi I; Kumagai Y; Inamura N; Majima M
    Br J Pharmacol; 1999 Nov; 128(6):1275-83. PubMed ID: 10578142
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
    Tomoda F; Lew RA; Smith AI; Madden AC; Evans RG
    Br J Pharmacol; 1996 Sep; 119(2):365-73. PubMed ID: 8886422
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Approaches to the development of novel antihypertensive drugs: crucial role of the renal kallikrein-kinin system.
    Majima M; Katori M
    Trends Pharmacol Sci; 1995 Jul; 16(7):239-46. PubMed ID: 7667898
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Role of the renal kallikrein-kinin system in the development of salt-sensitive hypertension.
    Katori M; Majima M; Hayashi I; Fujita T; Yamanaka M
    Biol Chem; 2001 Jan; 382(1):61-4. PubMed ID: 11258674
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Role of the renal kallikrein-kinin system in the development of hypertension.
    Katori M; Majima M
    Immunopharmacology; 1997 Jun; 36(2-3):237-42. PubMed ID: 9228552
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Crucial suppressive role of renal kallikrein-kinin system in development of salt-sensitive hypertension.
    Katori M; Majima M; Hayashi I
    Biol Res; 1998; 31(3):143-9. PubMed ID: 9830501
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Blood pressure regulation by the kallikrein-kinin system.
    Sharma JN; Uma K; Noor AR; Rahman AR
    Gen Pharmacol; 1996 Jan; 27(1):55-63. PubMed ID: 8742494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.